ONL Therapeutics
Pre-clinicalDevelops therapies to protect and regenerate retinal cells for ocular diseases.
Founded
2009
Focus
RNA & Gene TherapySmall Molecules
About
Develops therapies to protect and regenerate retinal cells for ocular diseases.
Funding History
3Total raised: $27.5M
Grant$2.5MNational Eye InstituteSep 15, 2020
Series B$15MUndisclosedMar 15, 2018
Series A$10MMichigan Economic Development CorporationJun 15, 2015
Company Info
TypePrivate
Founded2009
LocationAnn Arbor, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile